Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma

被引:0
|
作者
Mi Jeong Heo
Jessica Yun
Sang Geon Kim
机构
[1] Seoul National University,College of Pharmacy and Research Institute of Pharmaceutical Sciences
来源
Archives of Pharmacal Research | 2019年 / 42卷
关键词
Hepatocellular carcinoma; microRNA; Long non-coding RNA; Non-coding RNA;
D O I
暂无
中图分类号
学科分类号
摘要
Hepatocellular carcinoma (HCC) is a tumor with poor prognosis and frequently aggressive. The development of HCC is associated with fibrosis and cirrhosis, which mainly results from nonalcoholic fatty liver disease, excessive alcohol consumption, and viral infections. Non-coding RNAs (ncRNAs) are RNAs transcribed from the genome, but are not translated into proteins. Recently, ncRNAs emerged as key contributors to tumor development and progression because of their abilities to regulate various targets and modulate cell proliferation, differentiation, apoptosis, and development. In this review, we summarize the frequently activated pathways in HCC and discuss the pathological implications of ncRNAs in the context of human liver disease progression, in particular HCC development and progression. This review aims to summarize the role of ncRNA dysregulation in the diseases and discuss the diagnostic and therapeutic potentials of ncRNAs.
引用
收藏
页码:48 / 62
页数:14
相关论文
共 50 条
  • [1] Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma
    Heo, Mi Jeong
    Yun, Jessica
    Kim, Sang Geon
    ARCHIVES OF PHARMACAL RESEARCH, 2019, 42 (01) : 48 - 62
  • [2] Targeting ferroptosis: the role of non-coding RNAs in hepatocellular carcinoma progression and therapy
    Wang, Weijia
    Hashimi, Behishta
    Wang, Ping
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [3] Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular Carcinoma
    Manna, Debashri
    Sarkar, Devanand
    CANCERS, 2020, 12 (05)
  • [4] Non-Coding RNAs in Hepatocellular Carcinoma
    Korsch, Mascha
    Margetts, Alexander
    Wahlestedt, Claes
    Lohse, Ines
    LIVERS, 2022, 2 (03): : 185 - 213
  • [5] The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma
    Hu, Xinyao
    Zhu, Hua
    Shen, Yang
    Zhang, Xiaoyu
    He, Xiaoqin
    Xu, Ximing
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression
    Ahangar Davoodi, Nasrin
    Najafi, Sajad
    Naderi Ghale-Noie, Zari
    Piranviseh, Ashkan
    Mollazadeh, Samaneh
    Ahmadi Asouri, Sahar
    Asemi, Zatollah
    Morshedi, Mohammadamin
    Tamehri Zadeh, Seyed Saeed
    Hamblin, Michael R.
    Sheida, Amirhossein
    Mirzaei, Hamed
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [7] Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications
    Romeo, Mario
    Dallio, Marcello
    Scognamiglio, Flavia
    Ventriglia, Lorenzo
    Cipullo, Marina
    Coppola, Annachiara
    Tammaro, Chiara
    Scafuro, Giuseppe
    Iodice, Patrizia
    Federico, Alessandro
    CANCERS, 2023, 15 (21)
  • [8] Long non-coding RNAs in hepatocellular carcinoma
    Ge, Wen-jun
    Huang, Huan
    Wang, Tao
    Zeng, Wei-hong
    Guo, Min
    Ren, Chen-ran
    Fan, Ting-yu
    Liu, Fang
    Zeng, Xi
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
  • [9] The Emerging Role of Long Non-Coding RNAs in the Metastasis of Hepatocellular Carcinoma
    Chen, Xuejiao
    Tang, Feng-Ru
    Arfuso, Frank
    Cai, Wen-Qi
    Ma, Zhaowu
    Yang, Jiyuan
    Sethi, Gautam
    BIOMOLECULES, 2020, 10 (01)
  • [10] The Role of Non-Coding RNAs in Liver Disease, Injury, and Regeneration
    Rowe, Melissa M. M.
    Kaestner, Klaus H. H.
    CELLS, 2023, 12 (03)